Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 67 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

9%

6 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

46Total
Not Applicable (36)
Early P 1 (1)
P 1 (2)
P 2 (1)
P 3 (1)
P 4 (5)

Trial Status

Recruiting32
Not Yet Recruiting14
Completed10
Active Not Recruiting8
Enrolling By Invitation1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (67)

Showing 20 of 20 trials
NCT06734273Early Phase 1RecruitingPrimary

Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss

NCT07083557RecruitingPrimary

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

NCT06894498RecruitingPrimary

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

NCT06754163Phase 4Active Not RecruitingPrimary

Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients

NCT07542327Not Yet Recruiting

The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity

NCT06899997Not ApplicableRecruitingPrimary

Study of the Effects of Time-Restricted Feeding on the Immune Function of Individuals With Obesity

NCT07027969Phase 4Not Yet Recruiting

Metabolic Surgery for Atrial Fibrillation Elimination

NCT06803888Phase 4RecruitingPrimary

Bariatric Surgery vs. Semaglutide vs. Tirzepatide

NCT06924177Not ApplicableRecruitingPrimary

UTSW NORC Pilot Spinal Cord Injury Dietary Program

NCT06630663Not ApplicableRecruitingPrimary

A Wearable Device and AI-Supported Diet and Exercise Intervention

NCT06690905Phase 4Completed

Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population With Obesity

NCT06784297Unknown

INTERMEDIATE-SIZE PATIENT POPULATIONS EXPANDED ACCESS TO TREATMENT FOR SARCOPENIC OBESITY

NCT07049861Not ApplicableRecruiting

Advancing Biopsychosocial Care Training Initiative

NCT06795360Not ApplicableNot Yet RecruitingPrimary

Weight Changes After Incretin-mimetics

NCT06890975Not ApplicableNot Yet RecruitingPrimary

"F!reF!ghterF!t": Lifestyle Coaching Interventions for Obese Firefighters (FireFit)

NCT07178405Not ApplicableCompletedPrimary

Effects of Meal Characteristics on Appetite

NCT06924320Phase 1RecruitingPrimary

A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

NCT06768827Not ApplicableRecruiting

New Mechanisms of Obesity

NCT06790225Not ApplicableRecruiting

Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)

NCT06915090Not ApplicableCompleted

FIT-COACH: Fitbit Intervention With Coordinated Health Coaching and PCP Support

Scroll to load more

Research Network

Activity Timeline